Skip to content
  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
  • —
  • Sign in

Twitter
Instagram
TikTok
Linkedin
Youtube
Tumblr

Your cart

  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
FUNanc1al
0

Insider Purchases: Inside the Buy

Tag: PhilipBoudreau

Illustration depicting Abbott Laboratories as a futuristic healthcare city with FreeStyle Libre glucose sensors, cancer diagnostics trains labeled Cologuard and Cancerguard, happy doctors and patients, and a giant Dividend King castle.

June 24, 2026

🩺 Abbott Laboratories (ABT) Stock Analysis: Can a Dividend King Turn Exact Sciences Into Its Next Growth Engine?

Abbott Laboratories may not be flashy, but the healthcare giant combines insider buying, a growing oncology diagnostics platform, the dominant FreeStyle Libre franchise, and more than a century of dividend payments. With shares trading near 16x forward earnings, investors may be looking at a classic Growth at a Reasonable Price opportunity.

Read entire article

Tags: Abbott Laboratories, Abbott stock analysis, AbbottLaboratories, ABT, ABT stock, buy or sell ABT, cancer diagnostics, Cologuard, diagnostics stocks, dividend growth investing, Dividend King stocks, DividendKings, Exact Sciences acquisition, ExactSciences, featured-insiders, Frédéric Marsanne, FreeStyle Libre, FreeStyleLibre, FUNanc1al, GARP investing, healthcare innovation, healthcare stocks, hub-insiders, insider buying, InsiderBuying, medical devices, MedicalDevices, oncology investing, PhilipBoudreau, risks buying ABT, value investing, ValueInvesting, why buy ABT

Quick links

Search
About/Leadership
Editorial Process
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service

Contact us

@funanc1al
customer_service@funanc1al.com

About us

FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.

Follow us

Twitter
Instagram
TikTok
Linkedin
Youtube
Tumblr

© Copyright 2026 FUNanc1al
Powered by Shopify